Gustavo R. Sarria (@sarriagustavo) 's Twitter Profile
Gustavo R. Sarria

@sarriagustavo

Radiation Oncologist & Clinical Investigator 🇵🇪 🇩🇪 @UniklinikBonn. Global health advocate @Cancerrayos

ID: 380474006

linkhttps://orcid.org/0000-0002-5929-7270 calendar_today26-09-2011 18:18:16

106 Tweet

325 Followers

645 Following

Matthias Guckenberger (@mat_guc) 's Twitter Profile Photo

Virtual 5x5 symposium: Radiotherapy in maximum 5 fractions PANCREATIC CANCER Thursday June 10th 5:00 - 5:55 pm CEST Keynote speaker Prof M Hawkins, University College London "5 Fractions SBRT in Locally Advanced Pancreatic Cancer" #radonc Registration radio-onkologie.usz.ch/ueber-die-klin…

Virtual 5x5 symposium: Radiotherapy in maximum 5 fractions

PANCREATIC CANCER
Thursday June 10th 5:00 - 5:55 pm CEST

Keynote speaker
Prof M Hawkins, University College London
"5 Fractions SBRT in Locally Advanced Pancreatic Cancer"

#radonc 
Registration
radio-onkologie.usz.ch/ueber-die-klin…
Dr. Luis A. Pérez-Romasanta (@luisalberto3p) 's Twitter Profile Photo

¿Más cáncer de pulmón tras RT de la mama? Sí, pero la incidencia acumulada es baja: 3% a 20 años. Otra razón para aplicar DIBH (Deep Inspiration Breath Hold), APBI (Accelerated Partial Breast Irradiation) o IORT (Intra-operative RT). rdcu.be/cmeF1

¿Más cáncer de pulmón tras RT de la mama? Sí, pero la incidencia acumulada es baja: 3% a 20 años. Otra razón para aplicar DIBH (Deep Inspiration Breath Hold), APBI (Accelerated Partial Breast Irradiation) o IORT (Intra-operative RT).
rdcu.be/cmeF1
Prof Jayant Vaidya (@jsvaidya) 's Twitter Profile Photo

TARGIT-IORT radiotherapy during breast cancer lumpectomy: Better for patients Effective cancer treatment 4.4% fewer non-br ca deaths ie 900 less/yr Saves NHS £9m/y Safer during COVID NHS England NICE nature.com/articles/s4141… bmj.com/content/bmj/37… targit.org.uk

Deepak Gupta (@deepakonco) 's Twitter Profile Photo

Please join us on 21.07.18 at 7PM for an insteresting session by Prof Dr JUDIT BODA HEGGEMANN and Dr OLIVER BLANCK on Radiosurgery in Refractory Ventricular Tachycardia

Please join us on 21.07.18 at 7PM for an insteresting session  by Prof Dr JUDIT BODA HEGGEMANN  and Dr OLIVER BLANCK on Radiosurgery in Refractory Ventricular Tachycardia
The Lancet (@thelancet) 's Twitter Profile Photo

Radiation therapy plays a key role across the disease spectrum in most cancers—but the field is one of the most poorly understood of the cancer disciplines. This Review summarises developments and new frontiers for the non-radiation oncologist: hubs.li/H0RYt_K0

Radiation therapy plays a key role across the disease spectrum in most cancers—but the field is one of the most poorly understood of the cancer disciplines.

This Review summarises developments and new frontiers for the non-radiation oncologist: hubs.li/H0RYt_K0
Brian C. Baumann (@brianbaumannmd) 's Twitter Profile Photo

New editorial in the Red Journal on standard vs. hypofractionated bladder RT. Thanks to Paul Sargos and Jason Efstathiou. Hypofractionated RT is very promising but more studies are needed. Is online adaptive hypofractionated RT the future? sciencedirect.com/science/articl… ASTRO

RadOnc Tables (@radonctables) 's Twitter Profile Photo

New nomograms to replace Sedlis criteria 🚀 A better way to determine risk for post-op cervix ✨Nomograms for both SCC & ACC ✨Sedlis criteria is for 30% chance of recurrence, which is high. With this nomogram, those with other risk levels can be identified Matthew Culbert, MD 1/2

New nomograms to replace Sedlis criteria 🚀

A better way to determine risk for post-op cervix

✨Nomograms for both SCC & ACC

✨Sedlis criteria is for 30% chance of recurrence, which is high. With this nomogram, those with other risk levels can be identified 

<a href="/culbert_md/">Matthew Culbert, MD</a> 
1/2
Ane Appelt (@cancerphysicist) 's Twitter Profile Photo

Charlotte Coles reports the results from the IMPORT-HIGH trial. A masterclass in trial design and delivery - this is why the UK is rightly renowned for practice-changing #radonc trials - but also on how to report a trial clearly and succinctly 👏 #ESTRO2021

Charlotte Coles reports the results from the IMPORT-HIGH trial. A masterclass in trial design and delivery - this is why the UK is rightly renowned for practice-changing #radonc trials - but also on how to report a trial clearly and succinctly 👏 #ESTRO2021
Shalini Vinod (@shalinivinod13) 's Twitter Profile Photo

👏🏽👏🏽👏🏽⁦Shankar Siva on presentation of SAFRON II final results. Single fraction now standard of care for suitable pulmonary oligometastases, esp in COVID era? Equivalent cancer outcomes, SF 30% ⬇️ costs.⁩ ⁦TROG Cancer Research⁩ ⁦ESTRO⁩ #ESTRO2021

👏🏽👏🏽👏🏽⁦<a href="/_ShankarSiva/">Shankar Siva</a> on presentation of SAFRON II final results. Single fraction now standard of care for suitable pulmonary oligometastases, esp in COVID era? Equivalent cancer outcomes, SF 30% ⬇️ costs.⁩ ⁦<a href="/TROGfightcancer/">TROG Cancer Research</a>⁩ ⁦<a href="/ESTRO_RT/">ESTRO</a>⁩ #ESTRO2021
Radiation Oncology Institute-The ASTRO Foundation (@ro_institute) 's Twitter Profile Photo

#RadOnc residents - register at bit.ly/CRforVTreg for the FREE eContouring webinar on cardiac radioablation for ventricular tachycardia led by Dr. Cliff Robinson on 1/24 at 6 pm ET. Open to all but must be ARRO/ASTRO member-in-training for free registration.

#RadOnc residents - register at bit.ly/CRforVTreg for the FREE eContouring webinar on cardiac radioablation for ventricular tachycardia led by Dr. <a href="/SBRT_CR/">Cliff Robinson</a> on 1/24 at 6 pm ET. Open to all but must be <a href="/ARRO_org/">ARRO</a>/<a href="/ASTRO_org/">ASTRO</a> member-in-training for free registration.
Marianne Aznar (@marianneaznar) 's Twitter Profile Photo

As promised, here is a highlight of the physics papers in the new issue of Radiotherapy and Oncology, September 2021 issue! ESTRO @RadiotherapyOn1 Rob Coppes #medphys #radonc #editorlife

The Global Coalition for Radiotherapy (@globalrtco) 's Twitter Profile Photo

Thank you Anthony Zietman, Professor Pat Price and Sandra Turner for sharing your advocacy success stories at the GCR meeting. Watch in full bit.ly/3FQshSM. Let us know your thoughts and join us for our next meeting!

Robert Koch-Institut (@rki_de) 's Twitter Profile Photo

Nebenwirkungen, die unerwartet & erst lange nach der Impfung auftreten, sind bisher bei keiner Impfung beobachtet worden & sind auch bei den #COVID19-Impfstoffen nicht zu erwarten. Siehe FAQ: rki.de/SharedDocs/FAQ… Weitere Informationen zur Sicherheit bei Paul-Ehrlich-Institut #ÄrmelHoch

Nebenwirkungen, die unerwartet &amp; erst lange nach der Impfung auftreten, sind bisher bei keiner Impfung beobachtet worden &amp; sind auch bei den #COVID19-Impfstoffen nicht zu erwarten.
Siehe FAQ:
rki.de/SharedDocs/FAQ…
Weitere Informationen zur Sicherheit bei <a href="/PEI_Germany/">Paul-Ehrlich-Institut</a> #ÄrmelHoch
Prof Jayant Vaidya (@jsvaidya) 's Twitter Profile Photo

#COP26 TARGIT-IORT during lumpectomy for breast cancer, in addition to benefiting patients, would save 5 million miles (8 million km) of travel, 170000 woman-hours & 1200 tonnes of CO2 (a forest of 100 hectares) annually in the UK bmjopen.bmj.com/content/6/5/e0… youtu.be/uJr4YzZA21k

Prof Ananya💙 @achoud72.bsky.social (@achoud72) 's Twitter Profile Photo

Calling all #ClinOnc #Radonc Non-UK welcome Dont miss this opportunity with #WhereisHoskin! Great Clinical PhD funded by Cancer Research UK Involves #MRLinac #biomarkers #WhereisvanHerk Contact us to find out more Closing date 24/11 Alan McWilliam ESTRO ASTRO crukcentre.manchester.ac.uk/opportunities/…

Junzo Chino (@radoncology) 's Twitter Profile Photo

Confidence in performing #brachytherapy is low in residents both in Europe and US - despite this being a lifesaving skill. We need to do better in our training programs. American Brachy DrKamrava bit.ly/3GEaf92

Confidence in performing #brachytherapy is low in residents both in Europe and US - despite this being a lifesaving skill. We need to do better in our training programs. <a href="/AmericanBrachy/">American Brachy</a> <a href="/KamravaMD/">DrKamrava</a>  bit.ly/3GEaf92
M. Bolton (@5_utr) 's Twitter Profile Photo

Phase 2 HIFU for prostate cancer: 2-year failure rate after HIFU: 38% ⚠️ ⛔️ 👎 link.springer.com/article/10.100…